Geode Capital Management’s CoLucid Pharmaceuticals, Inc. CLCD Stock Holding History

Geode Capital Management’s Portfolio CLCD Stock Details CLCD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-53,805	Closed	-$1.96M	–	4121
2016 Q4	$1.96M	Buy	53,805 +5,082	+10%	+$180K	﹤0.01%	2633
2016 Q3	$1.86M	Buy	48,723 +22,834	+88%	+$338K	﹤0.01%	2605
2016 Q2	$211K	Hold	25,889	–	–	﹤0.01%	3574
2016 Q1	$160	Hold	25,889	–	–	﹤0.01%	3702
2015 Q4	$216K	Hold	25,889	–	–	﹤0.01%	3657
2015 Q3	$100K	Buy	+25,889	New	+$191K	﹤0.01%	3894

Other funds holding CLCD

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Geode Capital Management's CLCD Position: Q1 2017 in Review

Geode Capital Management sold out of CoLucid Pharmaceuticals, Inc. (CLCD) in Q1 2017, closing a stake of 53,805 shares — an estimated $1.96M sold.

Geode Capital Management first reported a position in CLCD in Q3 2015 and held it in 6 quarters. The position peaked at $1.96M in Q4 2016. 1 fund tracked by Wall St. Rank holds CLCD as of Q1 2017.

Geode Capital Management reported no remaining CoLucid Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
Geode Capital Management sold 53,805 CoLucid Pharmaceuticals, Inc. shares in Q1 2017, an estimated $1.96M.
Geode Capital Management first reported a position in CoLucid Pharmaceuticals, Inc. in Q3 2015 and held it in 6 quarters.
Geode Capital Management's CoLucid Pharmaceuticals, Inc. position peaked at $1.96M in Q4 2016.
1 fund tracked by Wall St. Rank held CoLucid Pharmaceuticals, Inc. as of Q1 2017.

Based on Geode Capital Management's 13F filing for Q1 2017, filed 12 May 2017.